Frequency and Etiology of Cytogenetically Cryptic Oncogenic Fusions in Pediatric AML

Explore the frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric Acute Myeloid Leukemia (AML) through this informative 14-minute conference talk presented by Gordana Raca at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Gain insights into the challenges of detecting these genomic alterations and their impact on accurate diagnosis and treatment of pediatric AML patients. Learn about the latest research findings and their implications for clinical cancer genomic testing. Understand the importance of advanced molecular techniques in identifying these cryptic fusions and how they contribute to improving patient outcomes. Discover the CGC's role in promoting best practices and education in clinical cancer genomics, aiming to ensure all cancer patients receive accurate genomic diagnoses for optimal therapy selection.

Frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric AML